Respiratory chain complex III deficiency with pruritus: A novel vitamin responsive clinical feature

[1]  Guido Kroemer,et al.  The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.

[2]  A. Munnich,et al.  Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. , 1997, The Journal of pediatrics.

[3]  G. Farrell,et al.  Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: Relevance to drug metabolism in experimental cholestasis , 1996, Journal of gastroenterology and hepatology.

[4]  P. Rustin,et al.  25 MITOCHONDRIAL RESPIRATORY CHAIN DISORDERS (MRCD) PRESENTING AS LIVER DISEASE: DIVERSITY OF CLINICAL, BIOCHEMICAL AND HISTOLOGICAL FEATURES , 1996 .

[5]  K. Byth,et al.  Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease , 1996, Journal of gastroenterology and hepatology.

[6]  J. Christodoulou,et al.  Leigh syndrome: Clinical features and biochemical and DNA abnormalities , 1996, Annals of neurology.

[7]  S. Krähenbühl,et al.  Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria , 1994, Hepatology.

[8]  A. Radominska,et al.  Bile Acid Metabolism and the Pathophysiology of Cholestasis , 1993, Seminars in liver disease.

[9]  D. Wallace,et al.  Oxidative Phosphorylation Diseases , 1990 .

[10]  J. Maris,et al.  Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P‐NMR follow‐up study , 1986, Annals of neurology.

[11]  B. Chance,et al.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Greim,et al.  Microsomal biotransformation system in cholestasis. , 1972, Progress in liver diseases.